Specialty Pharmacy

Glecaprevir and pibrentasvir (Mavyret) shows efficacy across hepatitis C genotypes.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses how to improve patient outcomes and decrease oncology spend.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Top news of the week from Specialty Pharmacy Times.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses why streamlining specialty pharmacy care is important.

The brain may stop the process of repairing myelin due to a blood clotting protein.

The type of inflammatory condition may increase the risk of liver disease, despite similar treatment.

Gaps in genome sequencing can lead to misdiagnosis for patients of non-European descent.

Two children with spinal muscular atrophy were able to walk without assistance after gene therapy.

Top news of the day from across the health care landscape.

Juluca is indicated as a complete therapy for patients with HIV-1.

The National Association of Specialty Pharmacy plans to submit comments about proposed Medicare changes.

Many immunotherapy clinical trials exclude HIV-positive patients with cancer.

The #APharmacistIs campaign demonstrates the value of pharmacists in improving the lives of patients.

Multiple mutations may work together to develop drug-resistant non-small cell lung cancer.

Guidelines suggest that patients with endocrine intestinal tumors should undergo surgery.

Top news of the day from across the health care landscape.

HIV-positive patients need to maintain healthy body weight, quit smoking, eat well, exercise regularly and treat hypertension, diabetes and dyslipidemia.

The FDA granted approval to numerous specialty drugs last week.

Customized technology may help specialty pharmacies drive adherence and patient outcomes.

Cetuximab-based imaging can detect brain cancer tumors as small as 10-mg.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the importance of disruption.

Top news of the day from across the health care landscape.

A cancer diagnosis in young patients can cause post-traumatic stress disorder that can persist long afterwards.

Doubling Medicare sequester cuts could reduce access to lower-cost cancer treatment.

Ron Lanton III, Esq, president, True North Political Solutions, LLC, takes a legal perspective on direct and indirect remuneration fees and how they affect specialty pharmacies.

Only 15% of patients with a 20% to 24% risk of breast cancer received a recommended MRI screening.

The FDA created a framework to create safe and effective regenerative medicine products.